Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998051790) A NOVEL NUCLEIC ACID MOLECULE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/051790 International Application No.: PCT/AU1998/000352
Publication Date: 19.11.1998 International Filing Date: 13.05.1998
Chapter 2 Demand Filed: 09.11.1998
IPC:
A61K 48/00 (2006.01) ,C12N 15/90 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
87
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
90
Stable introduction of foreign DNA into chromosome
Applicants:
AMRAD OPERATIONS PTY. LTD. [AU/AU]; 576 Swan Street Richmond, VIC 3121, AU (AllExceptUS)
CHOO, Kong-Hong, Andy [AU/AU]; AU (UsOnly)
DU SART, Desirée [AU/AU]; AU (UsOnly)
CANCILLA, Michael, Robert [AU/AU]; AU (UsOnly)
Inventors:
CHOO, Kong-Hong, Andy; AU
DU SART, Desirée; AU
CANCILLA, Michael, Robert; AU
Agent:
HUGHES, E., John, L. ; Davies Collison Cave 1 Little Collins Street Melbourne, VIC 3000, AU
Priority Data:
P0 678413.05.1997AU
P0 879126.08.1997AU
Title (EN) A NOVEL NUCLEIC ACID MOLECULE
(FR) NOUVELLE MOLECULE D'ACIDE NUCLEIQUE
Abstract:
(EN) The present invention is directed generally to an isolated nucleic acid molecule encompassing a neocentromere or a functional derivative thereof or a latent, synthetic or hybrid form therof and its use $i(inter alia) in developing a range of eukaryotic artificial chromosomes including mammalian (e.g. human) and non-mammalian artificial chromosomes. Such artificial chromosomes are useful in a range of genetic therapies.
(FR) La présente invention concerne généralement une molécule d'acide nucléique isolée comprenant un néocentromère ou un dérivé fonctionnel de cette dernière ou une forme latente, de synthèse ou hybride de cette dernière. L'invention traite également de l'utilisation de cette molécule, entre autres, pour développer une série de chromosomes artificiels eucaryotes comprenant des chromosomes artificiels de mammifères (par exemple l'homme) et non mammifères. Ces chromosomes présentent une grande utilité en thérapie génique.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0996719AU1998073258